<DOC>
	<DOCNO>NCT01367639</DOCNO>
	<brief_summary>Breast cancer ( BC ) major health problem prevalent cancer among women.In substantial proportion familial case , germ-line mutation either BRCA1/2 detect . The proven modality active risk reduction ( rather passive early detection ) , prophylactic surgery - prophylactic mastectomy oophorectomy . While majority Jewish mutation carrier elect undergo prophylactic oophorectomy age 40 year , Israel minority perform prophylactic mastectomy . Another ramification mutation carrier emotional stress associate discovery.Genetic information profound implication mutation carrier . The IBSR ( Inquiry-based stress reduction ) intervention , develop Byron Katie , train participant reduce perceive level stress self-inquiry thought belief connect stressful circumstance symptom . This meditative process , name `` The Work '' , enable participant identify question stressful thought cause suffering . The core IBSR simply four question turnaround , way experience opposite participant believe . This process simple , powerful provide skill self-inquiry management stressful thought easily implement daily life [ ] . Therefore , basis previous data beneficial observation postulate clinical utility IBSR mediation program may improve psychological physical symptom quality life among asymptomatic ( oncologically healthy ) BRCA1/ BRCA2 mutation carrier . Thus , conduct pilot randomize control trial scientifically investigate effect intervention effect BRCA1/2 mutation carrier .</brief_summary>
	<brief_title>Trial Inquiry Based Stress Reduction ( IBSR ) Program BRCA1/2 Mutation Carriers</brief_title>
	<detailed_description>Main Goals : To investigate whether IBSR intervention efficacious improve quality life , psychological physical status BRCA1/2 mutation carrier . Secondary-goal : To Assess feasibility IBSR intervention examine attendance , drop-out rate , program satisfaction . Hypothesis Participants ' ability deal emotional difficulty improve following participation IBSR intervention . This reflect improve value psychological measure , quality sleep , cancer relate worry , family support , depression anxiety , intervention ( among participant intervention group , control group ) . Study population : Eligible individual woman carrier one predominant Jewish mutation BRCA1/2 gene Meirav Center , Sheba Medical center past 10 year . All eligible woman contact staff Meirav Center offer participation routine follow visit high risk clinic , phone letter . Interested individual schedule attend meeting time convenience PI Co PIs explain study aim goal . After participant agree sign informed consent consider eligible .</detailed_description>
	<mesh_term>Hereditary Breast Ovarian Cancer Syndrome</mesh_term>
	<criteria>Women carrier one predominant Jewish mutation BRCA1/2 gene , age 35 year old , current past history cancer ( except BCC ) , willing sign inform consent , present mental clarity ability comprehend fulfill questionnaire . Diagnosed breast ovarian cancer cancer , self report Pregnancy , risk reduction mastectomy , severe psychiatric diagnosis ( e.g . bipolar disorder ) .</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>BRCA 1/2 Carriers</keyword>
	<keyword>IBSR</keyword>
	<keyword>The Work</keyword>
	<keyword>Randomized clinical trial</keyword>
</DOC>